MICRORNAS EXPRESSION IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE

被引：0
|
作者：
Fallah, Parviz [1 ]
Zamanizadeh, Ayeh [2 ]
Obeidi, Narges [3 ]
机构：
[1] Alborz Univ Med Sci, Sch Para Med, Karaj, Iran
[2] Razi Pathobiol Lab, Karaj, Iran
[3] Bushehr Univ Med Sci, Sch Para Med, Depart Dept Hematol, Bushehr, Iran
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2016年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase
    Fallah, P.
    Amirizadeh, N.
    Poopak, B.
    Toogeh, G.
    Arefian, E.
    Kohram, F.
    Rad, S. M. A. Hosseini
    Kohram, M.
    Naghadeh, H. Teimori
    Soleimani, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (04) : 560 - 568
  • [2] Circulating microRNAs expression profile in newly diagnosed and imatinib treated chronic phase - chronic myeloid leukemia
    Muniz Ferreira, Leticia Antunes
    Capannacci, Juliana
    Hokama, Newton Key
    Nogueira, Celia Regina
    Ceccarelli, Michele
    Cerulo, Luigi
    D'Angelo, Fulvio
    Montandon Hokama, Paula de Oliveira
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 805 - 811
  • [3] Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia
    O'Brien, SG
    Deininger, MWN
    SEMINARS IN HEMATOLOGY, 2003, 40 (02) : 26 - 30
  • [4] Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase
    Atallah, Ehab
    Cortes, Jorge
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) : 138 - 144
  • [5] Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007
    Mughal, Tariq
    Goldman, John M.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S95 - S101
  • [6] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [7] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [8] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Takahashi, Naoto
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Hino, Masayuki
    BLOOD, 2019, 134
  • [9] Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase
    Michihide Tokuhira
    Yuta Kimura
    Keiji Sugimoto
    Tomonori Nakazato
    Maho Ishikawa
    Isao Fujioka
    Tomoiku Takaku
    Noriyoshi Iriyama
    Eriko Sato
    Hiroyuki Fujita
    Yoshihiro Hatta
    Norio Komatsu
    Norio Asou
    Masahiro Kizaki
    Tatsuya Kawaguchi
    Medical Oncology, 2018, 35
  • [10] Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase
    Tokuhira, Michihide
    Kimura, Yuta
    Sugimoto, Keiji
    Nakazato, Tomonori
    Ishikawa, Maho
    Fujioka, Isao
    Takaku, Tomoiku
    Iriyama, Noriyoshi
    Sato, Eriko
    Fujita, Hiroyuki
    Hatta, Yoshihiro
    Komatsu, Norio
    Asou, Norio
    Kizaki, Masahiro
    Kawaguchi, Tatsuya
    MEDICAL ONCOLOGY, 2018, 35 (03)
12345